[go: up one dir, main page]

GB201013343D0 - Compositions and methods for inducing platelet aggregation - Google Patents

Compositions and methods for inducing platelet aggregation

Info

Publication number
GB201013343D0
GB201013343D0 GBGB1013343.7A GB201013343A GB201013343D0 GB 201013343 D0 GB201013343 D0 GB 201013343D0 GB 201013343 A GB201013343 A GB 201013343A GB 201013343 D0 GB201013343 D0 GB 201013343D0
Authority
GB
United Kingdom
Prior art keywords
compositions
platelet aggregation
methods
inducing platelet
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1013343.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queen Mary University of London
Original Assignee
Queen Mary and Westfiled College University of London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queen Mary and Westfiled College University of London filed Critical Queen Mary and Westfiled College University of London
Priority to GBGB1013343.7A priority Critical patent/GB201013343D0/en
Publication of GB201013343D0 publication Critical patent/GB201013343D0/en
Priority to PCT/GB2011/001190 priority patent/WO2012020218A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2086—IL-13 to IL-16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Provided are methods for inducing platelet aggregation in a subject. The methods comprise administering to the subject a composition comprising IL-17 and/or a fragment or variant thereof. Also provided are compositions comprising IL-17 and/or a fragment or variant thereof for use in inducing platelet aggregation in a subject and compositions comprising (i) IL-17 and/or a fragment or variant thereof, and (ii) one or more haemostatic agents.
GBGB1013343.7A 2010-08-09 2010-08-09 Compositions and methods for inducing platelet aggregation Ceased GB201013343D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1013343.7A GB201013343D0 (en) 2010-08-09 2010-08-09 Compositions and methods for inducing platelet aggregation
PCT/GB2011/001190 WO2012020218A1 (en) 2010-08-09 2011-08-09 Compositions and methods for inducing platelet aggregation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1013343.7A GB201013343D0 (en) 2010-08-09 2010-08-09 Compositions and methods for inducing platelet aggregation

Publications (1)

Publication Number Publication Date
GB201013343D0 true GB201013343D0 (en) 2010-09-22

Family

ID=42931373

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1013343.7A Ceased GB201013343D0 (en) 2010-08-09 2010-08-09 Compositions and methods for inducing platelet aggregation

Country Status (2)

Country Link
GB (1) GB201013343D0 (en)
WO (1) WO2012020218A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080014172A1 (en) * 2004-05-28 2008-01-17 Applied Research Systems Ars Holding N.V. Use of Il-17 in the Treatment of Fertility-Related Disorders

Also Published As

Publication number Publication date
WO2012020218A1 (en) 2012-02-16

Similar Documents

Publication Publication Date Title
MX2016007063A (en) Therapeutic peptides.
MY195289A (en) Anti IL-36R Antibodies
GB201106750D0 (en) Novel compounds
TN2014000134A1 (en) Therapeutic peptides
GB201106743D0 (en) Novel compounds
EP3082797A4 (en) Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof
IN2014DN06104A (en)
MX359639B (en) METHODS and COMPOSITIONS FOR USE IN CELLULAR THERAPIES.
IN2015DN03322A (en)
EA201591559A1 (en) THERAPEUTIC PEPTIDES
MX2013004061A (en) Cyclosporin analogs.
MX366368B (en) Prebiotic oral care methods using a saccharide.
SI2739615T1 (en) Phenyl-3-aza-bicyclo(3.1.0)hex-3-yl-methanones and the use thereof as medicament
EP2557927A4 (en) Fungicidal mixtures i comprising quinazolines
MX357284B (en) Quinone compounds for treating ape1 mediated diseases.
MY161601A (en) Films and compositions comprising the same
EA201390955A1 (en) ROBO1-FC fusion protein for use in the treatment of hepatocarcinoma
MX2013004062A (en) Cyclosporin analogs.
IN2014DN07326A (en)
MX2013003599A (en) Interferon-beta for use as monotherapy or in combination with other cancer therapies.
MX2016000294A (en) Pharmaceutical composition for a sustained release of lanreotide.
NZ717192A (en) Anti-inflammatory tripeptides
UA117567C2 (en) Galactagogue compositions based on phosphatidylserine
MX2013010947A (en) Gallium complexes, pharmaceutical compositions and methods of use.
GB201013343D0 (en) Compositions and methods for inducing platelet aggregation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)